Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 26.4.2008 | EN | Official Journal of the European Union | C 107/34 |

---

Action brought on 19 February 2008 — CureVac v OHIM — Qiagen (RNAiFect)

(Case T-80/08)

(2008/C 107/57)

Language in which the application was lodged: German

Parties

Applicant: CureVac GmbH (Tübingen, Germany) (represented by: F. von Stosch, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)

Other party to the proceedings before the Board of Appeal of OHIM: Qiagen GmbH (Hilden, Germany)

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | Annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (OHIM) of 11 December 2007 in Case R 1219/2006-1 relating to Opposition No B 771 495; |

|  |  |
| --- | --- |
| — | Refuse registration of Community trade mark No 3 304 813 |

|  |  |
| --- | --- |
| — | Order OHIM to pay the costs |

Pleas in law and main arguments

Applicant for a Community trade mark: Qiagen GmbH

Community trade mark concerned: The word mark ‘RNAiFect’ for goods in Classes 1, 5 and 9 (Application No 3 304 813)

Proprietor of the mark or sign cited in the opposition proceedings: The applicant

Mark or sign cited in opposition: the word mark ‘RNActive’ for goods in Classes 1 and 5 (Community trade mark No 2 953 768), albeit that the opposition was brought against registration in respect of certain goods in Classes 1 and 5

Decision of the Opposition Division: Rejection of the opposition

Decision of the Board of Appeal: Dismissal of the appeal

Pleas in law: Infringement of Article 8(1)(b) of Regulation (EC) No 40/94[(1)](#ntr1-C_2008107EN.01003401-E0001) as there is a likelihood of confusion between the opposing marks due to the identity of the goods and the similarity of the marks.

---

[Top](#document1)